PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30522955-5	2019	Notably, the novel pseudotripeptides influenced inflammatory cytokine expression (IL-1beta, IL-18, and TNF-alpha) in Abeta25-35-, PMA-, and LPS-treated THP-1 cells.	Tetradecanoylphorbol Acetate	130-133	interleukin 18	Homo sapiens	92-97	
24049660-11	2013	The significantly increased postchallenge concentrations of IL-2, IL-8, IL-12p70, IL-13, IL-18, IFN- gamma , TNF- alpha , and TGF- beta were released by peripheral blood cells after stimulation with PMA, as compared with both their prechallenge concentrations and with the PBS control values.	Tetradecanoylphorbol Acetate	199-202	interleukin 18	Homo sapiens	89-94	
27105502-8	2016	The in vitro study showed that MALT1 inhibitors decreased production of IL-1beta/IL-18 in phorbol myristate acetate-differentiated THP-1 cells and bone marrow derived macrophage via suppressing the activation of NF-kappaB and NLRP3 inflammasome.	Tetradecanoylphorbol Acetate	90-115	interleukin 18	Homo sapiens	81-86	
14979936-4	2004	RA-PBMCs activated with phytohemagglutinin and phorbol 12-myristate 13-acetate showed an increased sensitivity to IL-12 and IL-18, but still the RA-PBMC response was lower.	Tetradecanoylphorbol Acetate	47-78	interleukin 18	Homo sapiens	124-129	
16516851-4	2006	The IL-18 production by monocytes stimulated without or with LPS or A23187+PMA for 1day was measured by ELISA.	Tetradecanoylphorbol Acetate	75-78	interleukin 18	Homo sapiens	4-9	
19737478-1	2009	AIM: To determine the effects of triptolide (TP) on the expression of interleukin-18 (IL-18) and its receptor in phorbol 12-myristate 13-acetate (PMA)-stimulated rheumatoid arthritis synovial fibroblasts (RASF).	Tetradecanoylphorbol Acetate	113-144	interleukin 18	Homo sapiens	70-84	
19737478-1	2009	AIM: To determine the effects of triptolide (TP) on the expression of interleukin-18 (IL-18) and its receptor in phorbol 12-myristate 13-acetate (PMA)-stimulated rheumatoid arthritis synovial fibroblasts (RASF).	Tetradecanoylphorbol Acetate	113-144	interleukin 18	Homo sapiens	86-91	
19737478-1	2009	AIM: To determine the effects of triptolide (TP) on the expression of interleukin-18 (IL-18) and its receptor in phorbol 12-myristate 13-acetate (PMA)-stimulated rheumatoid arthritis synovial fibroblasts (RASF).	Tetradecanoylphorbol Acetate	146-149	interleukin 18	Homo sapiens	70-84	
19737478-1	2009	AIM: To determine the effects of triptolide (TP) on the expression of interleukin-18 (IL-18) and its receptor in phorbol 12-myristate 13-acetate (PMA)-stimulated rheumatoid arthritis synovial fibroblasts (RASF).	Tetradecanoylphorbol Acetate	146-149	interleukin 18	Homo sapiens	86-91	
18516710-1	2008	OBJECTIVE: To determine the effects of triptolide (TP) on the expression of interleukin-18 (IL-18) and its receptor in phorbol 12-myristate 13-acetate (PMA)-stimulated rheumatoid arthritis synovial fibroblasts (RASF).	Tetradecanoylphorbol Acetate	119-150	interleukin 18	Homo sapiens	76-90	
18516710-1	2008	OBJECTIVE: To determine the effects of triptolide (TP) on the expression of interleukin-18 (IL-18) and its receptor in phorbol 12-myristate 13-acetate (PMA)-stimulated rheumatoid arthritis synovial fibroblasts (RASF).	Tetradecanoylphorbol Acetate	119-150	interleukin 18	Homo sapiens	92-97	
18516710-1	2008	OBJECTIVE: To determine the effects of triptolide (TP) on the expression of interleukin-18 (IL-18) and its receptor in phorbol 12-myristate 13-acetate (PMA)-stimulated rheumatoid arthritis synovial fibroblasts (RASF).	Tetradecanoylphorbol Acetate	152-155	interleukin 18	Homo sapiens	76-90	
18516710-1	2008	OBJECTIVE: To determine the effects of triptolide (TP) on the expression of interleukin-18 (IL-18) and its receptor in phorbol 12-myristate 13-acetate (PMA)-stimulated rheumatoid arthritis synovial fibroblasts (RASF).	Tetradecanoylphorbol Acetate	152-155	interleukin 18	Homo sapiens	92-97	
10951141-5	2000	RESULTS: The IL-18 gene was constitutively transcribed by primary human keratinocytes and cell lines and was not significantly altered following exposure to IL-1 beta, tumour necrosis factor-alpha, interferon (IFN)-gamma, phorbol myristate acetate or nickel sulphate.	Tetradecanoylphorbol Acetate	222-247	interleukin 18	Homo sapiens	13-18	
12879265-6	2004	Specific protein kinase C activator phorbol myristate acetate reduced transcription and secretion of IL-18 in RA SF and OA SF.	Tetradecanoylphorbol Acetate	36-61	interleukin 18	Homo sapiens	101-106